If youre experiencing severe nausea accompanied by dehydration or an inability to eat, contact emergency health services
The combination of the very high price of these drugs typically about $1,000 per month per patient plus a relatively large number of patients who may benefit from them can result in a substantial net new cost to a health plan, potentially more than many employers or the employees who share the cost of coverage can afford
("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced that China's National Medical Products Administration (NMPA) has approved ecnoglutide injection for glycemic control in adults with type 2 diabetes mellitus (T2DM), making it the world's first approved cAMP-biased GLP-1 receptor agonist
Bonuses continue to attract attention, but their structure matters as much as their size
[1] If side effects significantly impair your quality of life despite timing adjustments, your prescriber may consider dose modification or alternative treatment options
